3XH-11658-00537
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 975 / OR
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Muscle or body achesAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-21
- 2021-01-22
-
2021-01-29
Survey response — day 14, dose 1MedDRA: Fatigue, Nasal congestion, Nasopharyngitis, Pain, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Runny nose & stuffy nose, body aches, mild fever, fatigue. Lasted approx 3 days..felf like a bad cold.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-05
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: I have a ton of energy & feel great!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Energy increased — Feeling: GoodFree text: Feeling super energized & great!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Energy increased, No adverse event — Feeling: GoodFree text: Feel great! Lots of energy!! :-)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Energy increased, Therapeutic response unexpected — Feeling: GoodFree text: Feel great..lots of energy :-)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-07
- 2021-08-06
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: COVID-19, Inflammation, Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had Delta covid in Septemberhad the remisvider treatmentended up having severe inflammation until Novembertook Famotidine & prednisonefelt better until first week of January when I got sick again..did not get tested but I am sure I hadMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech |
Free text
Release 3 — day 14, dose 1
Symptoms: Runny nose & stuffy nose, body aches, mild fever, fatigue. Lasted approx 3 days..felf like a bad cold.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I have a ton of energy & feel great!
Systemic reaction (other): Feeling super energized & great!
Systemic reaction (other): Feel great! Lots of energy!! :-)
Systemic reaction (other): Feel great..lots of energy :-)
Release 11 — 12 months, dose 2
Symptoms: I had Delta covid in Septemberhad the remisvider treatmentended up having severe inflammation until Novembertook Famotidine & prednisonefelt better until first week of January when I got sick again..did not get tested but I am sure I had
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Energy increased | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ○ |
| SRO | Therapeutic response unexpected | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release